Skip to main content

Rothblatt Martine A's Form 4 filing

United Therapeutics Corp (UTHR) · filed Apr 18, 2023

Accession no.
0001415889-23-006617
Filed
Apr 18, 2023
Trade date
Apr 14-17, 2023
Filing delay
4 days
Rule 10b5-1 plan
Not checked

This filing lists 9 non-derivative transactions and 2 derivative transactions. Open-market sales total $3.67M. It was filed 4 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Rothblatt Martine ACIK 0001106578Director, Officer (CHAIRPERSON & CEO)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Apr 14, 2023Common StockMOption exerciseAcquired+8,000$113.08+$904,6408,130Direct
Apr 14, 2023Common StockSSaleDisposed−3,463$227.90F2−$789,217.74,667Direct
Apr 14, 2023Common StockSSaleDisposed−3,692$228.65F3−$844,175.8975Direct
Apr 14, 2023Common StockSSaleDisposed−513$229.37F4−$117,666.81462Direct
Apr 14, 2023Common StockSSaleDisposed−332$231.39F5−$76,821.48130Direct
Apr 17, 2023Common StockMOption exerciseAcquired+8,000$113.08+$904,6408,130Direct
Apr 17, 2023Common StockSSaleDisposed−3,040$230.02F6−$699,260.85,090Direct
Apr 17, 2023Common StockSSaleDisposed−4,581$230.68F7−$1,056,745.08509Direct
Apr 17, 2023Common StockSSaleDisposed−379$231.54F8−$87,753.66130Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Apr 14, 2023Common StockMOption exerciseDisposed−8,000$0.00$096,000Direct
Apr 17, 2023Common StockMOption exerciseDisposed−8,000$0.00$088,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

This transaction was executed in multiple trades at prices ranging from $227.23 to $228.22. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F3

This transaction was executed in multiple trades at prices ranging from $228.235 to $229.18. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F4

This transaction was executed in multiple trades at prices ranging from $229.325 to $229.44. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F5

This transaction was executed in multiple trades at prices ranging from $230.90 to $231.865. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F6

This transaction was executed in multiple trades at prices ranging from $229.335 to $230.32. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F7

This transaction was executed in multiple trades at prices ranging from $230.34 to $231.335. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

F8

This transaction was executed in multiple trades at prices ranging from $231.39 to $231.625. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)